Cardionovum

Be up
to date.

Latest press release

Cardionovum - first transcontinental China-Europe Webinar on the treatment of complications in arteriovenous access in dialysis patients during COVID-19 pandemic.

Guest from Europe: Prof. Michael Lichtenberg (Germany) & Prof. Matteo Tozzi (Italy).

Video of European guests' speech.

Learn more >>

APERTO OTW® Drug Coated Balloon receives first Chinese NMPA Medical Device Registration Certificate for High Pressure DCB for Vascular Access

APERTO®, our innovative paclitaxel coated balloon for arterio-venous access, has received market approval for China. It is the the first high pressure drug coated balloon available in China to treat obstructive lesions of native Arterio Venous Dialysis Fistulae.

The approval was given based on the statistic results from the solidly designed clinical study in Chinese population:
APERTO AVF RCT CHINA.

Learn more >>

Online Seminar: "CARDIOLOGY CARING in COVID-19 PANDEMICS" China-EU

European Key Opinion Leaders as guests:

  • Prof. Dr. Horst Sievert , Frankfurt, Germany
  • Prof. Dr. Giuseppe Tarantini, Padua, Italy
  • Prof. Dr. Jacques Blacher, Paris, France

Video of European guests' speech.

Learn more >>

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum at Linc 2022

Cardionovum invites you to participate in a scientific session:

  • Pr. Matteo Tozzi will disclose the results of his study:
    Paclitaxel blood concentration after peripheral DCB PTA evaluated by HPLC

    Tuesday 7th June at 14,25h
    Speakers Corner

     

You are welcome to visit us at booth #10

Date: June 06, 2022–June 10, 2022

Location: Trade Fair Leipzig, Hall 2 - Seehausener Allee 1 - 04356 Leipzig, Germany

Learn more >>

Cardionovum at EuroPCR 2022

Cardionovum invites you to participate in 3 scientific sessions:

  • XLIMT trial with Dr. Luca Testa.
    Primary end point presentation.

    Available online:
    Poster Lab section
    17th-20th May

  • Restore SVD randomized trial with Dr. Changdong Guan.
    4 Year follow up presentation.

    On demand section:
    17th-20th May

  • HYPER study with Dr. Alfonso Ielasi.
    Primary end point presentation.

    In person presentation:
    Thursday 19th, 10:30- 12:00h Room Maillot

You are welcome to visit us at booth F6

Date: May 17, 2022–May 21, 2022

Location: France Palais des congrès, Paris

Learn more >>

Cardionovum GmbH at: "A glimpse into the future"

Cardionovum GmbH participates in:
The 1st symposium of interventional & clinical cardiology "A glimpse into the future". Dominican Society of Cardiology.

You are cordially invited to visit our booth.

Location: Convention Center, UTESA, Santiago, Dominican Republic

Download the program here (PDF)

Date: Jan 28, 2022–Jan 30, 2022

go top